Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2012
12/26/2012CN101439181B Stable water injection medicament composition containing Ulinastatin
12/26/2012CN101372511B Immunogenic peptide composition for the prevention and treatment of alzheimer's disease
12/26/2012CN101242812B Pancreatin micropellets suitable for enteric coating
12/26/2012CN101210051B Anti-VEGF antibodies
12/26/2012CN101146545B Mucin hypersecretion inhibitors based on the structure of MANS and methods of use
12/26/2012CN101139392B KDR peptides and vaccines containing the same
12/26/2012CN101106914B Novel nutraceutical compositions
12/26/2012CN100998864B Cyclosporin A semisolid skeleton capsule
12/25/2012US8338580 Fluorescent protein molecules
12/25/2012US8338575 IL-7 fusion proteins
12/25/2012US8338571 Recombinant factor VIII having increased stability
12/25/2012US8338565 Macrocyclic compounds for inhibition of tumor necrosis factor alpha
12/25/2012US8338545 Multi-arm block copolymers as drug delivery vehicles
12/25/2012US8338390 Multifunctional and biologically active matrices from multicomponent polymeric solutions
12/25/2012US8338385 Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor
12/25/2012US8338384 Method for treating ocular neovascularization
12/25/2012US8338381 Composition and method for the treatment of eye disease
12/25/2012US8338380 Use of the peptide RFMWMR as a therapeutic agent
12/25/2012US8338378 Neurotrophic peptides
12/25/2012US8338377 BMP-ALK3 antagonists and uses for promoting bone growth
12/25/2012US8338376 Compositions comprising variant LT-B-R-IG fusion proteins
12/25/2012US8338374 Storage stability, even after freeze-thaw; aqueous; buffer, stabilizing agents, including a nonionic surfactant (e.g. polysorbate 20), a polymer stabilizer (e.g. polyethylene glycol), and optional stabilizers such as magnesium salts, a tonicity agent, methionine, and a preservative
12/25/2012US8338373 Method for reducing the risk of spontaneous abortion in a human female subject
12/25/2012US8338372 Dehydroxy vancomycin, the preparation, pharmaceutical composition and the use
12/25/2012US8338371 Accelerated angiogenesis-inducing protein, compositions inducing accelerated angiogenesis and uses thereof
12/25/2012US8338370 Methods and compositions for promoting organ development
12/25/2012US8338369 Methods for administering long-lasting hypoglycemic agents
12/25/2012US8338368 Glucagon analogs exhibiting physiological solubility and stability
12/25/2012US8338367 Fused heteroaryl diamide compounds useful as MMP-13 inhibitors
12/25/2012US8338366 Bioactive FUS1 peptides and nanoparticle-polypeptide complexes
12/25/2012US8338365 Inhibiting integrin receptor binding with non-native monomeric disintegrin or monomeric disintegrin domains
12/25/2012US8338364 Peptide tyrosinase inhibitors and uses thereof
12/25/2012US8338363 Pharmaceutical compositions comprising casein derived peptides and methods of use thereof
12/25/2012US8338339 Process for inhibition of proteolytic activity during the ensiling of forages
12/25/2012US8338153 Recombinant hexose oxidase, a method of producing same and use of such enzyme
12/25/2012US8338150 Method for combined parallel agent delivery and electroporation for cell structures an use thereof
12/25/2012US8338136 Method of producing a paralytic peptide
12/25/2012US8338119 Chondroitinase ABC I and methods of degrading therewith
12/25/2012US8338115 Assays for detecting T2R76 taste modulatory compounds
12/25/2012US8338107 Method for producing polymers having a preselected activity
12/25/2012US8337873 Having hollow core, porosity on side walls, and comprising a biocompatible material that contains an encapsulated biological or chemical agent loaded in core, released by controlled release technology temporally and spatially, accelerating tooth or bone healing
12/25/2012US8337866 Porin B (PorB) as a therapeutic target for prevention and treatment of infection by chlamydia
12/25/2012US8337855 Anti-CD33 antibodies and methods for treatment of acute myeloid leukemia using the same
12/25/2012US8337847 Methods of treating anemia using anti-IL-6 antibodies
12/25/2012US8337837 Stable enzymatic preparations and methods of use thereof
12/25/2012US8337836 Methods for the treatment and prevention of diseases of biological conduits
12/25/2012US8337835 Use of an endogenous ligand for peroxisome proliferator activated receptor alpha to treat liver disorders
12/25/2012US8337834 Methods of making enhanced, autologous fat grafts
12/25/2012US8337833 Methods of improving central nervous system functioning
12/25/2012US8337828 Use of thymosin alpha 1, alone or in combination with PTX3 or ganciclovir, for the treatment of cytomegalovirus infection
12/25/2012US8337826 Active ingredient in a concentrate and a buffer; storage stability; free from human serum albumin
12/25/2012US8337825 Glycosaminoglycan-antagonising MCP-1 mutants
12/25/2012US8337817 Preparation for transnasal application
12/25/2012US8337815 Pulmonary surfactant formulations
12/20/2012WO2012174556A1 High capacity diketopiperazine microparticles
12/20/2012WO2012174522A1 Combined chemical modification of sphingosine-1-phosphate (s1p) and cxcr4 signalling pathways for hematopoietic stem cell (hsc) mobilization and engraftment
12/20/2012WO2012174489A2 Small molecule composite surfaces as inhibitors of protein-protein interactions
12/20/2012WO2012174481A1 Pharmaceutical compositions for intranasal administration for the treatment of neurodegenerative disorders
12/20/2012WO2012174480A2 Continuous subcutaneous insulin infusion methods with a hyaluronan degrading enzyme
12/20/2012WO2012174478A2 Stable formulations of a hyaluronan-degrading enzyme
12/20/2012WO2012174472A1 High capacity diketopiperazine microparticles
12/20/2012WO2012174455A2 Group a streptococcus multivalent vaccine
12/20/2012WO2012174452A1 Mitochondrial targeting and therapeutic use thereof
12/20/2012WO2012174423A1 Stabilized polypeptides as regulators of rab gtpase function
12/20/2012WO2012174412A2 Compositions targeting pkc-theta and uses and methods of treating pkc-theta pathologies, adverse immune responses and diseases
12/20/2012WO2012174409A1 Stabilized variant maml peptides and uses thereof
12/20/2012WO2012174397A2 Anti-inflammatory pharmaceutical products
12/20/2012WO2012174373A1 Methods of treating and inhibiting pathogens with resistance-mechanisms
12/20/2012WO2012174365A2 Methods for producing pancreatic precursor cells and uses thereof
12/20/2012WO2012174359A1 Methods for increasing insulin sensitivity and treating diabetes
12/20/2012WO2012174127A1 Proteases for degrading gluten
12/20/2012WO2012174123A1 Treatment of psychological trauma
12/20/2012WO2012174117A2 Aromatic-cationic peptides and uses of same
12/20/2012WO2012174055A1 Wound healing using complement inhibitors
12/20/2012WO2012174028A2 Peptide compositions and methods for treating lung injury, asthma, anaphylaxis, angioedema, systemic vascular permeability syndromes, and nasal congestion
12/20/2012WO2012173984A2 Gβγ BINDING SITE ON THE PIK3CB GENE PRODUCT AND METHODS OF USE
12/20/2012WO2012173846A2 Peptidomimetic macrocycles
12/20/2012WO2012173762A1 Cyclic lactadherin peptide mimetics and their uses
12/20/2012WO2012173422A1 A conjugate comprising oxyntomodulin and an immunoglobulin fragment, and use thereof
12/20/2012WO2012172887A1 Therapeutic agent for heart diseases and cell sheet for treating heart diseases
12/20/2012WO2012172521A1 Soluble proteins for use as therapeutics
12/20/2012WO2012172433A2 A sustained-release composition containing peptides as active ingredient
12/20/2012WO2012172318A1 Formulations containing tropolonoids, copper salt and a solvent system
12/20/2012WO2012172072A1 Freeze-dried formulations of fgf-18
12/20/2012WO2012172042A1 Vaccines for chlamydia
12/20/2012WO2012171994A1 Multi substituted insulins
12/20/2012WO2012171429A1 Polyethylene glycol-interferon conjugate
12/20/2012WO2012171332A1 Macrocyclic heterocyclic compound for inhibiting hepatitis c virus and preparation and use thereof
12/20/2012WO2012171231A1 Uses of protein acrosin and the preparation method thereof
12/20/2012WO2012171084A1 Polymer insulin encapsulation system, process and use of said system
12/20/2012WO2012151279A3 Induction of il-12 using immunotherapy
12/20/2012WO2012144726A3 Tumor antigen proteins or genes of polo-like kinase 1
12/20/2012WO2012115437A3 Pharmaceutical composition for cancer treatment or metastasis inhibition containing expression or activation inhibitors of map7d2 protein, novel cancer therapeutic target
12/20/2012WO2012106463A3 Cardiotrophin related molecules for enhanced therapeutics
12/20/2012WO2012102529A3 Composition for regulating circadian rhythms, composition for diagnosing circadian rhythm disorders and diagnostic kit
12/20/2012WO2011110716A3 Peptide compounds that can be used as antibacterial agents
12/20/2012US20120324593 Lysyl Oxidase-Like 1 (LOXL1) and Elastogenesis
12/20/2012US20120323162 Methods and Compositions for Treating Conditions of the Eye
12/20/2012US20120322858 Compositions and Methods for Inhibiting Expression of a Mutant Gene
12/20/2012US20120322850 Trpm-2 antisense therapy
1 ... 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 ... 3163